arrow
M

Masataka Sawaki

nagoya medical center
H指数:25
被引数:2,192

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

HER2DX in older patients with HER2-positive early breast cancer: extended follow-up from the RESPECT trial of trastuzumab ± chemotherapy

HER2DX在HER2阳性早期乳腺癌老年患者中的应用:来自RESPECT试验中曲妥珠单抗±化疗的扩展随访研究

2025-11-040
OAAI
Comparison of proportions and prognostic impact of pathological complete response between evaluations of representative specimen and total specimen in primary breast cancer after neoadjuvant chemoradiotherapy: an ancillary study of JCOG0306
2024-06-270
OAAI
Clinical benefit of post-trastuzumab deruxtecan treatment in patients with HER 2-positive unresectable or metastatic breast cancer: A single-institution retrospective observational study

曲妥珠单抗后deruxtecan治疗对不可切除或转移性乳腺癌患者的临床益处: 一项单机构回顾性观察研究

2024-05-260
PRE
Pilot trial of an electronic patient-reported outcome monitoring system in patients with metastatic breast cancer undergoing chemotherapy

接受化疗的转移性乳腺癌患者的电子患者报告结局监测系统的试点试验

2024-01-045
OA
Adjuvant trastuzumab without chemotherapy for treating early HER2-positive breast cancer in older patients: A propensity score-adjusted analysis of a prospective cohort study
BREAST
IF7.9
2022-12-015
OAAI